Zensights LLC
Laura Mezey is an accomplished legal and business executive with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as an Independent Director on the Audit, Risk Management & Compliance Committee at OTSUKA AMERICA PHARMACEUTICAL INC, Laura also holds the position of Entrepreneur In Residence at DigitalDx Ventures, focusing on innovative investments in AI, diagnostics, and personalized medicine. As a Subject Matter Expert at Zensights LLC, Laura facilitates partnerships within BioPharma Commercial Operations. Previously, Laura held significant leadership roles at Bayer, including Vice President, Integration, Separation and Transitions, where major business transformations were led. With a robust legal background as Global Division Counsel at Bayer HealthCare, Laura has managed corporate legal matters and compliance in heavily regulated environments. Education includes a JD from New York University School of Law, a Bachelor of Science in Foreign Service from Georgetown University, and a Certificat d'Etudes Politiques from Sciences Po.
This person is not in the org chart
This person is not in any teams
Zensights LLC
Zensights partners with commercial teams, finance, and procurement within large and emerging pharmaceutical and biotech companies. Zensights solutions combine our proprietary software tools and informational resources about business and clinical operations with the fresh perspectives of our robust Zensights Executive Network and our seasoned Executive Leadership Team. This combination allows us to vet potential vendors and implement creative customer-centric solutions based on our best-in-class playbooks. Our solutions go beyond uncovering the right vendors for our clients’ delivery of commercial services; they also identify the “A-Team” resources within each vendor organization. We provide insights and implementations that our clients need and cannot get anywhere else – demonstrated through higher ROIs and savings, and transparent, synergistic vendor relationships.